Categories: News

Kinova signs a 5-year contract extension to continue supporting cutting-edge robotic surgery

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MONTREAL, Feb. 23, 2022 /PRNewswire/ – Kinova®, a privately-held developer of robotic solutions, announced today the signing of a five-year agreement for robots manufacturing and development with Auris Health, Inc., a subsidiary of Ethicon, Inc., part of the Johnson & Johnson Medical Devices Companies since 2019, with the option to extend for a further three years. As part of the agreement, Kinova will continue to support Auris in the expansion of the MONARCH® Platform, leveraging the firm’s capacity and expertise to deliver integrated and cost-effective robotic solutions.

Since 2015, Kinova has had a strategic agreement with Auris for the MONARCH® Platform, a first-of-its-kind robotic technology indicated for use in diagnostic and therapeutic bronchoscopic procedures. Through this agreement, Kinova worked with the team at Auris to define and develop a purpose-built robotic arm to help enable meaningful progress in surgery.

“An important part of Kinova’s vision is to use medical robotics for optimal patient outcomes and enable humans in the process with better tools. We have worked with the Auris team to advance the development of disruptive robotic solutions for the last 6 years, and we are excited to continue our strategic agreement to help advance the frontier of surgery.” said Charles Deguire, CEO & Co-Founder of Kinova. “The MONARCH® Platform demonstrates perfectly Kinova’s capacity to support the robotization, through strategic partnerships and collaborative efforts, of global leaders in the medical device space. Robotics has evolved, there’s this new generation of connected and integrated robots, and we are committed to enabling companies to take full advantage of it.”

About Kinova
Kinova Inc., headquartered in Boisbriand (Greater Montreal), Quebec, Canada, is a leader in innovative robotics. Founded in 2006, the company designs and manufactures robots for various markets, including medical robotics, assistive robotics, research and education, and more recently industrial and professional automation. Kinova’s ingenious technology improves and extends the capabilities of customers with a human-first approach to serve the growing need for robotics across increasingly complex industries. kinovarobotics.com  

View original content:https://www.prnewswire.com/news-releases/kinova-signs-a-5-year-contract-extension-to-continue-supporting-cutting-edge-robotic-surgery-301488072.html

SOURCE Kinova Robotics

Staff

Recent Posts

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

24 hours ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

24 hours ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

24 hours ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

24 hours ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

24 hours ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…

24 hours ago